Research examines peptide degradation, formulation stability, excipient compatibility, release kinetics, mucosal transport, and structural characteristics that may influence bioavailability
Clinical trials using oral glucose tolerance testing demonstrated that AOD-9604 has no negative impact on carbohydrate metabolism or insulin sensitivity
Step 5: Select and clean your injection site Choose from one of three primary subcutaneous injection sites: the abdomen (most common), the front of the thigh, or the back of the upper arm
Yes, just like your body needs nutrients to function, your hair does too
Blood samples were analysed to identify the presence of anti-AOD 9604 antibodies, to dismiss immunogenicity
This method injects the peptide directly into the abdominal cavity